Cardiomyopathy

  • Cardiomyopathy Research

    The Heart Institute at Cincinnati Children’s is one of the most productive pediatric academic medical centers for cardiomyopathy research in the country, as evidenced by our dollars received and papers published.

    In fiscal year 2010, we published 33 cardiomyopathy-related peer-reviewed publications.

    Additionally, our experts are world-renowned leaders in the field and have written the standards of care and treatment for cardiomyopathy patients.

    We don’t just diagnose and treat cardiomyopathy, we conduct research into the causes and treatments of this disease, ensuring bench-to-beside application as quickly as possible.

    Recently, we established a new standard of care based on Jeffrey Towbin’s research findings that 39 percent of children who undergo heart transplants often develop coronary artery disease due to viral infections after surgery. As a result, on follow-up, we now biopsy myocardium from all transplant patients for viral PCR testing through our Heart Institute Diagnostic Laboratory.

    If the biopsy shows the child has a viral infection, we treat with intravenous immunoglobulin, which boosts the child’s immune system’s ability to fight off infection.

    Under the direction of leading cardiomyopathy experts Jeffrey Towbin and Stephanie Ware, the Heart Institute has been integral in the advancement of the genetic causes of cardiomyopathy and interventions in treatment.

    Our research has lead to significant findings in cardiomyopathy:

    Our cardiomyopathy grant funding totals more than $3.6 million.

 
 
 
 
  • Heart Institute

    Learn about what makes the Heart Institute a national and international leader in clinical cardiology care and research.

    Read more